Swiss National Iodine Survey 2020

November 21, 2023 updated by: Isabelle Herter-Aeberli
This study will assess iodine status in school aged children and pregnant women is Switzerland. In addition, thyroid status and omega-3 index will be assessed in pregnant women.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

875

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zurich, Switzerland, 8092
        • Human Nutrition Laboratory, ETH Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 44 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Both groups: nationally representative sample selected through schools (children) and gynecologists (women).

School aged children: aged between 6 and 12 years Pregnant women: aged between 18 and 44 years, pregnant

Description

Inclusion Criteria:

  • Healthy
  • for pregnant women: confirmed pregnancy
  • living in Switzerland for min 1 year

Exclusion Criteria:

  • no history of major medical illness
  • no iodine containing contrast agents or medication in the past 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pregnant women
There is not intervention
School aged children
There is not intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urinary iodine concentration
Time Frame: Baseline
urinary iodine concentration in spot urine samples
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urinary creatinine concentration
Time Frame: Baseline
Urinary creatinine concentration in spot urine samples
Baseline
Urinary sodium concentration
Time Frame: Baseline
Urinary sodium concentration in spot urine samples
Baseline
Urinary fluoride concentration
Time Frame: Baseline
Urinary fluoride concentration in spot urine samples
Baseline
Thyroid stimulating hormone
Time Frame: Baseline
TSH from dried blood spots
Baseline
T3
Time Frame: Baseline
T3 from dried blood spots
Baseline
T4
Time Frame: Baseline
T4 from dried blood spots
Baseline
Omega 3 index
Time Frame: Baseline
Omega 3 index from dried blood spots
Baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height
Time Frame: Baseline
Baseline
Weight
Time Frame: Baseline
Baseline
Omega 3 intake
Time Frame: Baseline
Assessment of omega 3 intake using a food frequency questionnaire
Baseline
Depressive symptoms
Time Frame: Baseline
Assessment of depressive symptoms using the Edinburgh Postnatal Depression Scale (EPDS).
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2020

Primary Completion (Actual)

August 31, 2022

Study Completion (Actual)

July 30, 2023

Study Registration Dates

First Submitted

August 12, 2020

First Submitted That Met QC Criteria

August 19, 2020

First Posted (Actual)

August 24, 2020

Study Record Updates

Last Update Posted (Actual)

November 22, 2023

Last Update Submitted That Met QC Criteria

November 21, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2020-00192

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on There is no intervention. It is an observational study.

Subscribe